What is Cronos Group's earnings per share (EPS)?

Cronos Group (CRON) reported diluted earnings per share of $-0.02 for fiscal year 2025. This represents a -118.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cronos Group Financials

CRON

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Cronos Group (CRON) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRON FY2025 2026-05-11

Margin repair is pulling Cronos close to operating break-even, while a cash-heavy balance sheet keeps the transition self-funded.

Gross margin expansion from 21.4% to 42.8% shows the core economics improved enough to pull the business much closer to operating break-even. That progress mattered more than the headline loss of -$2.9M, because operating cash flow still rose to $25.9M, making cash generation a cleaner read on operating progress than net income.

With $791.8M of cash and only $54.2M of total liabilities, the company is not using leverage as its bridge to improvement. This is a very equity-funded balance sheet, so management has room to keep adjusting the cost base without the pressure of material debt service.

Free cash flow was just $149K even though operating cash flow reached $25.9M, because reinvestment absorbed almost all of that cash. That is a major shift from the larger cash burn seen earlier, but it also shows the business has only recently crossed from funding losses to roughly funding itself.

Financial Health Signals

Financial Health Score 74/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cronos Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Safe

13.33

Cronos Group scores 13.33, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.1B) relative to total liabilities ($54.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Cronos Group passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-8.92x

For every $1 of reported earnings, Cronos Group generates $-8.92 in operating cash flow ($25.9M OCF vs -$2.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$146.6M

YoY+24.6%

5Y CAGR+25.7%

Cronos Group generated $146.6M in revenue in fiscal year 2025. This represents an increase of 24.6% from the prior year.

EBITDA

-$3.2M

YoY+95.3%

Cronos Group's EBITDA was -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 95.3% from the prior year.

Net Income

-$2.9M

YoY-107.3%

Cronos Group reported -$2.9M in net income in fiscal year 2025. This represents a decrease of 107.3% from the prior year.

EPS (Diluted)

$-0.02

YoY-118.2%

Cronos Group earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 118.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$149K

YoY-97.7%

Cronos Group generated $149K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 97.7% from the prior year.

Cash & Debt

$791.8M

YoY-7.8%

5Y CAGR-6.0%

Cronos Group held $791.8M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

382M

YoY-0.2%

5Y CAGR+1.2%

Cronos Group had 382M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Margins & Returns

Gross Margin

42.8%

YoY+21.4pp

5Y CAGR+98.1pp

Cronos Group's gross margin was 42.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 21.4 percentage points from the prior year.

Operating Margin

-11.9%

YoY+53.2pp

5Y CAGR+457.7pp

Cronos Group's operating margin was -11.9% in fiscal year 2025, reflecting core business profitability. This is up 53.2 percentage points from the prior year.

Net Margin

-2.0%

YoY-36.0pp

5Y CAGR+154.6pp

Cronos Group's net profit margin was -2.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 36.0 percentage points from the prior year.

Return on Equity

-0.3%

YoY-4.0pp

5Y CAGR+4.0pp

Cronos Group's ROE was -0.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.0 percentage points from the prior year.

Capital Allocation

R&D Spending

$4.4M

YoY+5.2%

5Y CAGR-26.2%

Cronos Group invested $4.4M in research and development in fiscal year 2025. This represents an increase of 5.2% from the prior year.

Share Buybacks

$9.7M

Cronos Group spent $9.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$25.7M

YoY+107.2%

5Y CAGR-3.9%

Cronos Group invested $25.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 107.2% from the prior year.

CRON Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$146.6M+24.6%	$117.6M+34.8%	$87.2M+0.6%	$86.7M+34.4%	$64.6M+38.2%	$46.7M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$62.8M+149.1%	$25.2M+111.6%	$11.9M-22.8%	$15.4M+187.7%	-$17.6M+31.9%	-$25.8M
R&D Expenses	$4.4M+5.2%	$4.2M-27.6%	$5.8M-55.5%	$13.1M-39.9%	$21.8M+7.2%	$20.4M
SG&A Expenses	$42.0M-9.7%	$46.5M-6.0%	$49.5M-26.9%	$67.7M-25.6%	$90.9M+12.8%	$80.6M
Operating Income	-$17.4M+77.3%	-$76.5M+9.8%	-$84.8M+23.9%	-$111.4M+61.8%	-$292.0M-33.1%	-$219.4M
Interest Expense	N/A	N/A	N/A	$13K-51.9%	$27K-85.5%	$186K
Income Tax	-$14.2M-313.0%	-$3.4M-6.4%	-$3.2M-109.5%	$34.2M+8029.2%	-$431K-132.0%	$1.3M
Net Income	-$2.9M-107.3%	$40.0M+154.1%	-$73.9M+56.2%	-$168.7M+57.4%	-$396.1M-441.6%	-$73.1M
EPS (Diluted)	$-0.02-118.2%	$0.11+157.9%	$-0.19+57.8%	$-0.45+57.9%	$-1.07-409.5%	$-0.21

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$45.2M+1.5%	$44.5M+22.5%	$36.3M+8.6%	$33.5M+3.7%	$32.3M+6.5%	$30.3M-11.6%	$34.3M+23.4%	$27.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$19.2M+18.3%	$16.2M-11.7%	$18.3M+26.4%	$14.5M+5.6%	$13.7M+27.1%	$10.8M+199.3%	$3.6M-42.7%	$6.3M
R&D Expenses	$1.4M+2.2%	$1.4M+2.8%	$1.3M+44.8%	$929K+17.2%	$793K-22.9%	$1.0M-17.2%	$1.2M+29.1%	$962K
SG&A Expenses	$11.7M-9.0%	$12.9M+39.4%	$9.3M-12.2%	$10.5M+13.2%	$9.3M-22.9%	$12.1M-5.3%	$12.8M-0.1%	$12.8M
Operating Income	-$1.8M+75.5%	-$7.5M-1390.3%	-$503K+90.6%	-$5.3M-30.7%	-$4.1M+64.2%	-$11.4M+66.2%	-$33.7M-116.3%	-$15.6M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$2.4M+120.4%	-$11.9M-803.9%	-$1.3M-150.7%	-$525K-15.4%	-$455K-122.7%	$2.0M+174.0%	-$2.7M-24.6%	-$2.2M
Net Income	$13.8M+190.7%	$4.7M-81.8%	$26.0M+165.4%	-$39.7M-748.7%	$6.1M-85.6%	$42.6M+410.8%	$8.3M+195.3%	-$8.8M
EPS (Diluted)	$0.04	N/A	$0.07+170.0%	$-0.10-600.0%	$0.02	N/A	$0.02+200.0%	$-0.02

CRON Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.2B+2.6%	$1.2B+2.3%	$1.1B-6.0%	$1.2B-13.2%	$1.4B-27.4%	$1.9B
Current Assets	$944.1M+0.9%	$936.1M+0.3%	$933.3M-2.8%	$960.2M-11.1%	$1.1B-21.3%	$1.4B
Cash & Equivalents	$791.8M-7.8%	$858.8M+28.3%	$669.3M-12.5%	$764.6M-13.8%	$887.0M-17.7%	$1.1B
Inventory	$46.8M+41.0%	$33.1M+8.7%	$30.5M-18.8%	$37.6M+14.5%	$32.8M-25.5%	$44.0M
Accounts Receivable	$34.1M+120.5%	$15.5M+10.6%	$14.0M-39.5%	$23.1M+4.7%	$22.1M+147.2%	$8.9M
Goodwill	$66.5M+4.8%	$63.5M+5903.1%	$1.1M+2.3%	$1.0M-5.9%	$1.1M-99.4%	$179.5M
Total Liabilities	$54.2M-2.1%	$55.3M+25.3%	$44.1M-38.7%	$72.0M+13.5%	$63.5M-70.8%	$217.5M
Current Liabilities	$48.2M-3.0%	$49.7M+20.1%	$41.4M-39.2%	$68.1M+25.3%	$54.4M-73.7%	$206.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.1B+2.8%	$1.1B-3.2%	$1.1B-3.9%	$1.1B-14.5%	$1.3B-21.9%	$1.7B
Retained Earnings	$447.8M-2.2%	$457.7M+9.8%	$416.7M-15.1%	$490.7M-25.6%	$659.4M-38.1%	$1.1B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.2B-2.1%	$1.2B+1.6%	$1.2B+0.3%	$1.2B+1.9%	$1.2B-1.1%	$1.2B-1.5%	$1.2B+8.5%	$1.1B
Current Assets	$927.9M-1.7%	$944.1M+2.4%	$922.2M-0.5%	$927.1M+0.9%	$918.6M-1.9%	$936.1M-2.4%	$959.2M+2.6%	$935.3M
Cash & Equivalents	$821.9M+3.8%	$791.8M+1.0%	$784.2M-1.3%	$794.4M-0.4%	$797.8M-7.1%	$858.8M-0.4%	$862.0M+1.6%	$848.2M
Inventory	$48.7M+4.1%	$46.8M-2.9%	$48.2M+14.3%	$42.1M+21.8%	$34.6M+4.4%	$33.1M-29.8%	$47.3M+61.9%	$29.2M
Accounts Receivable	$33.0M-3.3%	$34.1M+25.9%	$27.1M+1.8%	$26.6M+42.2%	$18.7M+21.0%	$15.5M-24.5%	$20.5M+26.6%	$16.2M
Goodwill	$65.4M-1.6%	$66.5M+1.6%	$65.4M-2.2%	$66.9M+5.8%	$63.3M-0.3%	$63.5M+66.9%	$38.0M+3613.7%	$1.0M
Total Liabilities	$48.3M-10.9%	$54.2M+16.9%	$46.4M+3.0%	$45.0M+15.3%	$39.1M-29.4%	$55.3M+4.7%	$52.8M+49.8%	$35.3M
Current Liabilities	$42.4M-12.0%	$48.2M+17.3%	$41.1M+9.2%	$37.6M+13.8%	$33.0M-33.5%	$49.7M+25.6%	$39.6M+19.7%	$33.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.1B-1.8%	$1.1B+1.1%	$1.1B0.0%	$1.1B+1.5%	$1.1B+0.2%	$1.1B-1.6%	$1.1B+2.1%	$1.1B
Retained Earnings	$460.5M+2.9%	$447.8M-0.5%	$450.0M+6.1%	$424.1M-8.6%	$463.8M+1.3%	$457.7M+10.6%	$414.0M+2.1%	$405.6M

CRON Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$25.9M+37.3%	$18.8M+144.0%	-$42.8M+51.8%	-$88.9M+42.1%	-$153.6M-6.0%	-$144.9M
Capital Expenditures	$25.7M+107.2%	$12.4M+395.4%	$2.5M-27.4%	$3.5M-69.0%	$11.1M-64.5%	$31.4M
Free Cash Flow	$149K-97.7%	$6.4M+114.2%	-$45.3M+50.9%	-$92.4M+43.9%	-$164.8M+6.5%	-$176.3M
Investing Cash Flow	-$76.6M-143.7%	$175.1M+394.4%	-$59.5M-3130.1%	-$1.8M+93.6%	-$28.9M-243.4%	$20.1M
Financing Cash Flow	-$19.9M-1517.0%	-$1.2M-19.5%	-$1.0M+64.4%	-$2.9M+78.4%	-$13.4M-340.6%	-$3.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$9.7M	$0	$0	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$10.9M-7.9%	$11.8M-11.1%	$13.3M+372.3%	$2.8M+234.4%	-$2.1M-127.2%	$7.7M-33.4%	$11.6M+564.2%	$1.7M
Capital Expenditures	$1.9M-12.3%	$2.1M-52.3%	$4.5M+16.8%	$3.8M-74.9%	$15.3M+330.7%	$3.5M-44.8%	$6.4M+780.0%	$729K
Free Cash Flow	$9.0M-6.9%	$9.7M+9.9%	$8.8M+966.1%	-$1.0M+94.1%	-$17.4M-515.5%	$4.2M-19.2%	$5.2M+409.2%	$1.0M
Investing Cash Flow	$38.0M+1267.0%	$2.8M+112.1%	-$23.0M-2240.0%	-$983K+98.2%	-$55.4M-1000.1%	-$5.0M-515.2%	-$818K+90.4%	-$8.6M
Financing Cash Flow	-$18.3M-146.1%	-$7.4M-297.8%	-$1.9M+75.7%	-$7.7M-162.3%	-$2.9M-836.1%	-$313K-2307.7%	-$13K+95.0%	-$260K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$16.7M+291.8%	$4.3M+129.7%	$1.9M-48.5%	$3.6M	$0	$0	$0	N/A

CRON Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	42.8%+21.4pp	21.4%+7.8pp	13.7%-4.1pp	17.8%+45.0pp	-27.3%+28.0pp	-55.3%
Operating Margin	-11.9%+53.2pp	-65.1%+32.1pp	-97.2%+31.3pp	-128.4%+323.8pp	-452.2%+17.3pp	-469.6%
Net Margin	-2.0%-36.0pp	34.0%+118.7pp	-84.7%+109.8pp	-194.5%+419.1pp	-613.5%-457.0pp	-156.5%
Return on Equity	-0.3%-4.0pp	3.8%+10.5pp	-6.7%+8.0pp	-14.8%+14.9pp	-29.6%-25.4pp	-4.3%
Return on Assets	-0.2%-3.7pp	3.4%+9.9pp	-6.5%+7.4pp	-13.9%+14.4pp	-28.3%-24.5pp	-3.8%
Current Ratio	19.59+0.8	18.84-3.7	22.54+8.4	14.10-5.8	19.86+13.2	6.63
Debt-to-Equity	0.050.0	0.05+0.0	0.04-0.0	0.06+0.0	0.05-0.1	0.13
FCF Margin	0.1%-5.4pp	5.5%+57.4pp	-52.0%+54.5pp	-106.5%+148.7pp	-255.2%+122.1pp	-377.3%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	42.4%+6.0pp	36.4%-14.1pp	50.4%+7.1pp	43.4%+0.8pp	42.6%+6.9pp	35.7%+25.1pp	10.5%-12.1pp	22.7%
Operating Margin	-4.0%+12.8pp	-16.8%-15.4pp	-1.4%+14.5pp	-15.9%-3.3pp	-12.6%+24.9pp	-37.5%+60.7pp	-98.2%-42.2pp	-56.0%
Net Margin	30.4%+19.8pp	10.6%-60.8pp	71.4%+190.1pp	-118.7%-137.7pp	19.0%-121.8pp	140.8%+116.4pp	24.4%+55.9pp	-31.5%
Return on Equity	1.3%+0.9pp	0.4%-2.0pp	2.4%+6.1pp	-3.7%-4.2pp	0.6%-3.4pp	4.0%+3.2pp	0.8%+1.6pp	-0.8%
Return on Assets	1.2%+0.8pp	0.4%-1.8pp	2.2%+5.6pp	-3.4%-3.9pp	0.5%-3.1pp	3.7%+2.9pp	0.7%+1.5pp	-0.8%
Current Ratio	21.87+2.3	19.59-2.9	22.45-2.2	24.65-3.1	27.80+9.0	18.84-5.4	24.24-4.0	28.29
Debt-to-Equity	0.040.0	0.050.0	0.040.0	0.040.0	0.04-0.0	0.050.0	0.05+0.0	0.03
FCF Margin	20.0%-1.8pp	21.8%-2.5pp	24.3%+27.3pp	-3.0%+50.7pp	-53.8%-67.6pp	13.8%-1.3pp	15.1%+11.4pp	3.7%

Similar Companies

TILRAY BRANDS INC TLRY

$497.5M

Dynavax Technolo DVAX

$1.8B

Evotec Ag EVO

$682.0M

Pacira Biosciences Inc PCRX

$1.0B

Akebia Therapeut AKBA

$343.4M

Frequently Asked Questions

What is Cronos Group's annual revenue?

Cronos Group (CRON) reported $146.6M in total revenue for fiscal year 2025. This represents a 24.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cronos Group's revenue growing?

Cronos Group (CRON) revenue grew by 24.6% year-over-year, from $117.6M to $146.6M in fiscal year 2025.

Is Cronos Group profitable?

No, Cronos Group (CRON) reported a net income of -$2.9M in fiscal year 2025, with a net profit margin of -2.0%.

What is Cronos Group's EBITDA?

Cronos Group (CRON) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Cronos Group's gross margin?

Cronos Group (CRON) had a gross margin of 42.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cronos Group's operating margin?

Cronos Group (CRON) had an operating margin of -11.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cronos Group's net profit margin?

Cronos Group (CRON) had a net profit margin of -2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cronos Group's return on equity (ROE)?

Cronos Group (CRON) has a return on equity of -0.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cronos Group's free cash flow?

Cronos Group (CRON) generated $149K in free cash flow during fiscal year 2025. This represents a -97.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cronos Group's operating cash flow?

Cronos Group (CRON) generated $25.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cronos Group's total assets?

Cronos Group (CRON) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cronos Group's capital expenditures?

Cronos Group (CRON) invested $25.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Cronos Group spend on research and development?

Cronos Group (CRON) invested $4.4M in research and development during fiscal year 2025.

Does Cronos Group buy back shares?

Yes, Cronos Group (CRON) spent $9.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cronos Group have outstanding?

Cronos Group (CRON) had 382M shares outstanding as of fiscal year 2025.

What is Cronos Group's current ratio?

Cronos Group (CRON) had a current ratio of 19.59 as of fiscal year 2025, which is generally considered healthy.

What is Cronos Group's debt-to-equity ratio?

Cronos Group (CRON) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cronos Group's return on assets (ROA)?

Cronos Group (CRON) had a return on assets of -0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cronos Group's Altman Z-Score?

Cronos Group (CRON) has an Altman Z-Score of 13.33, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cronos Group's Piotroski F-Score?

Cronos Group (CRON) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cronos Group's earnings high quality?

Cronos Group (CRON) has an earnings quality ratio of -8.92x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Cronos Group?

Cronos Group (CRON) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.